SLC22A5 Mutations in a Patient With Systemic Primary Carnitine Deficiency and Cleft Palate-Successful Perioperative Management

The Journal of Craniofacial Surgery
Ching-Wei HuLun-Jou Lo

Abstract

Primary systemic carnitine deficiency (SCD) is an autosomal-recessive disorder caused by SLC22A5 gene mutation resulting in defective cellular carnitine transporter organic cation transporter 2. Defective carnitine transporter causes renal carnitine wasting and low serum carnitine. Carnitine is an essential cofactor for the transportation of long-chain fatty acids into the mitochondria. Lacking of carnitine may cause metabolic decompensation and sudden death when the patient is exposed to prolonged fasting before an operation. An asymptomatic 9-month-old boy with SCD diagnosed by local hospital was referred to the authors' hospital for incomplete cleft palate plastic surgery. Due to potential metabolic decompensation from prolonged fasting before the surgery, the patient underwent proper perioperative management. The operation was successful and subsequent clinical course was fine. The patient was discharged on postoperative day 3. With proper perioperative management, patients with SCD and cleft palate can survive from prolonged fasting time before and during operation without metabolic decompensation manifestations. Early recognition of SCD and perioperative management can be lifesaving in preoperative infants with SCD.

References

Nov 1, 1991·Anesthesia and Analgesia·O N Elpeleg
Aug 1, 1997·The Journal of Pediatrics·P RinaldoH J Stern
Aug 5, 2003·Intensive Care Medicine·F FeilletP E Bollaert
Jul 9, 2004·American Journal of Physiology. Cell Physiology·Karim LahjoujiGrant A Mitchell
Dec 14, 2004·Annals of the New York Academy of Sciences·Charles A Stanley
Sep 30, 2005·Anesthesiology·Shoichi UezonoMakoto Ozaki
Apr 8, 2006·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Nicola LongoMarzia Pasquali
May 30, 2006·Anesthesiology·Guy L Weinberg, Verna Baughman
Nov 28, 2006·Molecular Genetics and Metabolism·Lisa A SchimmentiNicola Longo
Dec 23, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Ayman W El-HattabLee-Jun Wong
Jan 16, 2010·Molecular Genetics and Metabolism·Ni-Chung LeeWuh-Liang Hwu
Jun 23, 2010·Journal of Inherited Metabolic Disease·Dau-Ming NiuKwang-Jen Hsiao
Sep 20, 2012·Orphanet Journal of Rare Diseases·Pilar L Magoulas, Ayman W El-Hattab

❮ Previous
Next ❯

Citations

Apr 26, 2019·The Journal of Craniofacial Surgery·Charles ChampeauxYohan Caudron

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.